Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

Clinical trial NCT03876301 · COMPLETED

Trial details

NCT number: NCT03876301
Sponsor: Spark Therapeutics, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Blood Coagulation Disorder Blood Coagulation Disorders, Inherited Coagulation Protein Disorders Hemophilia A Genetic Diseases, Inborn Genetic Diseases, X-Linked Hematologic Diseases Hemorrhagic Disorders Factor VIII Deficiency

Start date: 2019-01-21
Primary completion: 2023-05-02
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.